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Abstract
Activation of the innate immune system by free heme has been proposed as one of
the principal consequences of cell-free hemoglobin (Hb) exposure. Nonetheless, in the
absence of infection, heme exposures within a hematoma, during hemolysis, or upon
systemic administration of Hb (eg, as a Hb-based oxygen carrier) are typically not
accompanied by uncontrolled inflammation, challenging the assumption that heme is a
major proinflammatory mediator in vivo. Because of its hydrophobic nature, heme lib-
erated from oxidized hemoglobin is rapidly transferred to alternative protein-binding
sites (eg, albumin) or to hydrophobic lipid compartments minimizing protein-free heme
under in vivo equilibrium conditions. We demonstrate that the capacity of heme to
activate human neutrophil granulocytes strictly depends on the availability of non pro-
tein-associated heme. In human endothelial cells as well as in mouse macrophage cell
cultures and in mouse models of local and systemic heme exposure, protein-asso-
ciated heme or Hb do not induce inflammatory gene expression over a broad range of
exposure conditions. Only experiments in protein-free culture medium demonstrated
a weak capacity of heme-solutions to induce toll-like receptor-(TLR4) dependent TNF-
alpha expression in macrophages. Our data suggests that the equilibrium-state of free
and protein-associated heme critically determines the proinflammatory capacity of the
metallo-porphyrin. Based on these data it appears unlikely that inflammation-promot-
ing equilibrium conditions could ever occur in vivo.
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heme, hemoglobin, inflammation, innate immunity, protoporphyrin IX, sickle cell disease
1 | INTRODUCTION
Damage-associated molecular patterns (DAMPs) signal a disruption
in tissue homeostasis to the immune system, initiating and
amplifying inflammatory and regenerative responses.1 Over the last
several years, an increasing number of reports have suggested that
Hb-derived heme could be such an endogenous danger signal, trig-
gering inflammation whenever red blood cells (RBCs) are destroyed
and Hb released into extracellular spaces.2,3
Cell-free Hb is considered an amplifier of disease in a range
of pathologies.2 The most archetypical condition associated with
Abbreviations: TLR4, toll-like receptor-4; DAMPs, Damage-associated molecular patterns;
RBCs, red blood cells; Hb, hemoglobin; PHZ, phenylhydrazine hydrochloride; HUVECs,
heme exposure in endothelial cells.
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extravascular Hb and heme release occurs when RBCs extravasate
after a tissue trauma resulting in blood vessel injury and RBC
leakage, causing either a hematoma or a contusion. Over time,
these extravascular RBCs break down, releasing Hb and other cel-
lular components. In contrast, systemic release of free Hb occurs
during intravascular hemolysis, such as sickle cell disease or trans-
fusion-associated hemolysis.4 Extensive clinical experience suggests
that hematomas, contusions, and systemic hemolysis are not usu-
ally associated with an exaggerated proinflammatory response. In
contrast, cases of simple contusions presenting with cardinal signs
of inflammation like edema, redness, and pain would raise con-
cerns of an infection.5 Therefore, it would be more intuitive to
assume that the accumulation of Hb in damaged tissues promotes
noninflammatory or even anti-inflammatory instead of proinflam-
matory effects. However, paradoxical observations have been
reported in the literature over the last decade. Several studies
have described proinflammatory signaling activities of heme via
the activation of pattern recognition receptors such as TLR4 or
the inflammasome signaling pathway in leukocytes and endothelial
cells.3,6-13
An essential caveat of these opposing hypotheses regarding the
function of heme in the regulation of inflammation may be deter-
mined by its macromolecular associations. Heme is a lipophilic
molecule, which forms (mu-oxo) dimers, oligomers, and larger aggre-
gates in aqueous solutions.14-16 Therefore, heme exists almost
exclusively bound within a hemoprotein (eg, Hb) in biological envi-
ronments. Under certain conditions, such as after the oxidation of
Hb to ferric metHb (HbFe3+), the association of heme with the
hemoprotein (eg, globin) weakens.17,18 However, even under these
conditions, the binding of the “released” metallo-porphyrin by other
macromolecules such as albumin or lipids keeps the pool of “free”
heme low.14 By this mechanism, free heme accumulation in vivo
remains orders of magnitude below the conditions under which
protein-free heme-solutions have been tested for proinflammatory
activities in vitro.
Here, we present data obtained from several in vitro and in vivo
models that support the more intuitive hypothesis that protein-asso-
ciated heme originating from RBC degradation does not induce
inflammation.
2 | METHODS
2.1 | Heme preparation
2.1.1 | Preparation of heme-albumin
Hemin (65 mg; Sigma 51280) was dissolved in 10 mL NaOH
(100 mmolL1) at 37°C, and then 15 mL of 20% human serum-albu-
min (CSL Behring AG) was added. After 1 hour of incubation at
37°C, the pH of the solution was adjusted to pH 7.8 using phospho-
ric acid. The 4 mmolL1 heme-albumin solution was sterile-filtered
(0.22 lm) and used immediately.
2.1.2 | Preparation of heme-NaOH
Heme was dissolved in 10 mL NaOH (100 mmolL1) at 37°C. The
pH of the solution was adjusted to pH 7.8 using phosphoric acid.
The solution was sterile-filtered (0.22 lm) and used immediately.
The purified Hb solutions that we used were described previously.
metHb (ferric) was generated by incubating oxyHb (ferrous) with a
5 9 molar excess of K3[Fe(CN)6] at room temperature for 10 min-
utes, followed by purification on a PD-10 column (GE Healthcare).
Hemoglobin concentrations and oxidation states were determined by
spectral deconvolution, as described.19 Hemoprotein and heme con-
centrations are indicated as molar concentrations of heme.
2.2 | Quantification of free heme by stopped-flow
spectrophotometry
Heme or hemoproteins were diluted in PBS, pH 7.4, to a final con-
centration of 5 lmolL1 in a stopped-flow cell. Transfer of heme to
hemopexin (Hx) was measured at a 29 molar excess of Hx as a
change in absorbance at 411 nm. Absorbance was measured every
12.5 ms with a stopped-flow spectrophotometer (SX18MV; Applied
Photophysics Ltd., Leatherhead, UK). Each experiment was con-
ducted in triplicate. Absorbance data were fitted to a three-phase
kinetics model to define heme fractions with fast, intermediate, and
slow heme-hemopexin transfer using the R statistical software.
2.3 | Cell culture
2.3.1 | Endothelial cell culture
Human umbilical vein endothelial cells (HUVECs) were obtained from
Lonza (Switzerland) and cultured in EGM medium (Lonza) under
standard conditions.
2.3.2 | Macrophage differentiation and stimulation
Mouse bone marrow-derived macrophages (BMDMs) were expanded
and differentiated in RPMI medium supplemented with 10% FCS in
the presence of recombinant mouse M-CSF (Peprotech) for 7 days.
At the end of the culture period, 100% of adherent cells were posi-
tive for F4/80 antigen.
2.3.3 | Neutrophil stimulation and flow cytometry
Fresh human donated blood was purchased from the Swiss Red Cross
(SRK Blutspendedienst, Schlieren). The buffy coat was harvested in
DPBS MgCl2/CaCL2 (Gibco #14040) containing 500 IE/mL heparin by
washing three times with DPBS MgCL2/CaCL2 and centrifuging at
400g for 10 minutes at 4°C. After the final wash, the supernatant was
aspirated, and the cells were stimulated with heme at 37°C. Cells were
put on ice immediately, and after centrifugation at 400g for 10 min-
utes at 4°, cells were stained with CD15-FITC antibody (Ab; Miltenyi
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Biotec #130-081-101), APC-CD14 (BD Biosciences #555399), and
PE-CD62L (BD Biosciences #341012). Erythrocytes were lyzed with
lyzing buffer (8.29 g ammonium chloride, 1 g potassium hydrogen car-
bonate, 0.037 g Na-EDTA per L) at room temperature for 1 minute.
Residual cells were analyzed by cytometry with a FACSCalibur (Becton
Dickinson) flow cytometer. Neutrophil activation was measured by
shedding of CD62L Ab (PE-CD62L; BD Biosciences #341012). Data
were analyzed using CellQuest Pro software, and logistic regression
was performed with the R statistical software.
2.4 | ATP measurement and metabolic flux analysis
A chemiluminescent assay was used to measure cellular ATP (CellTi-
ter-Glo Assay; Promega AG, Dubendorf, Switzerland). Experiments
were performed in 96-well plates, and luminescence was measured
with an Infinite M200-Pro plate reader (Tecan Group Ltd,
M€annedorf, Switzerland).
Mitochondrial function (oxygen consumption rate) and glycolysis
(acidification rate) were measured with confluent monolayers of
HUVECs with a Seahorse XFp extracellular flux analyzer and the Cell
Mito Stress Kit (Seahorse Bioscience) according to the instructions
provided by the manufacturer.
2.5 | Western blotting
Samples were prepared with 5 lg of total protein per well in L€ammli
buffer. The western blot protocol was previously described and
included chemiluminescence detection of the secondary HRP-labeled
antibodies (Amersham, GE Healthcare, Glattbrugg, Switzerland) with
the SuperSignal West Femto Maximum Sensitivity Substrate (Thermo
Scientific AG). Images were optimized only by adjusting the bright-
ness and contrast of the whole image using Photoshop Software
(Adobe, Adobe Systems GmbH, Z€urich, Switzerland). The primary
antibodies were pAb anti-Hmox1 antibody (Enzo Life Sciences #ADI-
SPA-895) at a final concentration of 0.2 lg/L.
2.6 | Gene expression analysis
2.6.1 | Microarray experiments and data analysis
Total RNA was isolated using the RNeasy Mini Kit according to the
manufacturer’s instructions, which included an on-column DNA
digestion step (RNase-Free DNase Set; Qiagen Hombrechtikon,
Switzerland). To ensure that only high-quality RNA (RNA integrity
number >7.0) was used for gene expression analysis, each RNA sam-
ple was checked on an RNA Nanochip with a Bioanalyzer 2100 (Agi-
lent Technologies). RNA was quantified spectrophotometrically with
a NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies,
Wilmington, DE, USA). Fluorescently labeled cRNA was generated
from 500 ng total RNA with the Quick Amp Labeling Kit (Agilent
Technologies) according to the manufacturer’s protocol, and differen-
tial gene expression profiling was performed by competitive dual-
color hybridization on whole mouse or human Genome Oligo
Microarrays (mouse: G4846A, human: G4845A, 4 9 44 K, Agilent
Technologies). Array slides were XDR-scanned and analyzed with
Feature Extraction Software Version 10.7.3.1 (Agilent Technologies).
Statistical analysis and visualization was performed with JMP Geno-
mics 7.0 (SAS Institute, Boeblingen, Germany). Full gene array data
were submitted to the gene expression omnibus.
2.6.2 | Real-time PCR
Reverse transcription was performed with TaqMan reverse transcrip-
tion reagents (Life Technologies, Basel, Switzerland). Real-time PCR
was performed using the TaqMan Fast Advanced Master mix and
TaqMan gene expression assays (Life Technologies) with FAM-
labeled probes for the following targets: IL-6 (Mm00446190_m1),
TNF-alpha (Mm00443258_m1), and Hprt (Mm01545399_m1_m1).
Relative mRNA levels were calculated by the 7500 Fast System
Sequence Detection Software Version 1.4 (Applied Biosystems) after
normalization of each experimental sample to Hprt levels.
2.7 | Bio-Plex cytokine assays
Concentrations of TNF-alpha, IL-6, and IL-8 were determined using
Bio-Plex Cytokine Assays (Bio-Rad). The assays were analyzed with a
Bio-Plex 200 system (Bio-Rad). Results were analyzed using Bio-Plex
Data Pro software (Bio-Rad).
2.8 | VCAM1 cell surface expression
HUVECs were prestimulated with the indicated hemoprotein for
4 hour before stimulation with IL-1b (100 U/mL) for an additional
4 hour. Cells were fixed with 3.7% formaldehyde in PBS and perme-
abilized with 0.1% Triton-X in PBS. Cells were blocked with LI-COR
Odyssey Blocking Buffer (#P/N 927) and incubated with anti-
hVCAM-1 (#BBA19, 1:8000, RnDsystem). Cells were washed three
times with 0.1% Tween-20 in PBS and incubated with IRDye
800CW donkey anti-goat (1 lg/mL; LI-COR #926-32214) and Cell-
TagTM 700 stain (0.1 lmolL1; LI-COR #P/N 926-41090) or
DRAQ5TM (0.5 lmolL1; Cell Signaling Technologies #4084S). Cells
were washed again three times and analyzed with an Odyssey infra-
red imager from LI-COR and Odyssey software.
2.9 | Animal experiments
Wild-type C57Bl/6 mice were obtained from Charles River (Wilming-
ton, MA, USA). BMDM were also generated from Tlr4-, Myd88-, and
Trif-deficient mice Charles River (Wilmington, MA, USA). Heme oxy-
genase (Hmox1)-deficient macrophages were generated from B6.Cg-
Tg(UBC-cre/ERT2)1Ejb/J x B6.129S-Hmox1 mice.
2.9.1 | Matrigel plug assay
8-week-old C57Bl/6 mice were injected subcutaneously with 0.2 mL
of Matrigel (Corning) containing 1 mmolL1 heme-albumin or LPS
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(1 lg/mL). The injected Matrigel rapidly formed a single, solid gel
plug. After 5 days the Matrigel plug was removed, fixed in formalin,
and embedded in paraffin. Sections (3–5 lm thick) were prepared,
mounted on glass slides, deparaffinized in xylene, rehydrated through
graded alcohols, and stained with hematoxylin and eosin (HE) and
Abs against F4/80 (Invitrogen MA5-16363 poly R6), Lys6G (Biole-
gend 127602), and iNOS (EMD Millipore, ABN26). All slides were
scanned using a digital slide scanner (NanoZoomer-XR C12000,
Hamamatsu, Japan), images were taken using NDP.view2 software
(Hamamatsu).
2.9.2 | Laser microdissection
Freshly removed Matrigel plugs were embedded in OTC and frozen
in liquid-nitrogen-cooled methanol. Cryosections (8 lm) were
mounted on polyethylene naphthalate (PEN) membrane frame glass
slides (LCM0522, ThermoFisher Scientific). PEN membrane slides
were gradually hydrated to water/ethanol (1:1), stained with 4% cre-
syl violet (LCM Staining Kit, AM1935, Ambion), washed in water/
ethanol, dehydrated to 100% ethanol, and cleared with 100% xylene.
RNase contamination was avoided by cleaning surfaces and tools
with RNase Zap solution. Regions of interest of sectioned Matrigel
plugs were outlined manually and tagged digitally using an Arcturus
XTTM Microdissection System equipped with a Nikon TE2000U
brightfield microscope, cut by a digitally guided solid state UV laser,
and glued to CapSure Micro LCM caps (A30153, ThermoFisher Sci-
entific) by solid state infrared laser pulses. Film on caps containing
specific biological material was removed by sterile forceps, trans-
ferred to 20 lL RT buffer, and frozen in dry ice before RNA isolation
by iScript Reverse Transcription Supermix (Cat. 170-8842, BioRad).
2.9.3 | PHZ-induced systemic hemolysis
C57Bl/6 mice were treated intraperitoneally (i.p.) with 90 mg/kg phenyl-
hydrazine hydrochloride (PHZ). Livers were collected, and macrophages
were purified from cell suspensions by F4/80-conjugated microbeads
and magnetic cell separation columns (Miltenyi) according to the manu-
facturer’s protocol (Miltenyi). The purity of isolated cells was confirmed
by FACS and was always >80%. The concentration of heme was quanti-
fied in F4/80+ macrophages using the oxalic acid method of Sassa et al.
20 using oxalic acid from Sigma-Aldrich.
2.10 | Study approval
All experimental protocols were reviewed and approved by the Veteri-
nary Office of the canton of Z€urich. All animals were maintained at the
animal facility of the University of Zurich and were treated in accor-
dance with guidelines of the Swiss federal Veterinary Office.
3 | RESULTS
3.1 | Solution characteristics determine neutrophil
activation by free heme
Neutrophil granulocytes are known to be very sensitive to exposure to
diverse inflammatory stimuli that ultimately trigger a conserved activa-
tion response, including the shedding of cell surface E-selectin (SELE).
Exposure of washed human peripheral blood leukocytes to protein-
free crystalline heme that has been dissolved in NaOH (100 mmolL1)
with subsequent adjustment to pH 7.8 resulted in a drastic reduction
in cell surface CD62L expression on CD14lowCD15high neutrophil
granulocytes after 30 minutes of exposure (Figure 1A). This effect
was comparable to the effect induced by TNF-alpha. The effect of
heme was dose-dependent with 100% shedding at micromolar con-
centrations, as demonstrated by the logistic regression model shown
in Figure 1B (aggregated data from 5 healthy blood donors with heme
exposure assessed at 10 concentrations from 108 to 101 mol/L, see
also Figure S1). In the next set of experiments, we compared the neu-
trophil-activating effect of NaOH-dissolved heme with the effects of
more physiological protein-associated heme, namely, heme-albumin
and metHb (HbFe3+) (Figure 2C). Protein association of heme with
albumin or Hb shifted the dose-response curve for neutrophil CD62L
shedding to the right by several orders of magnitude. By modeling the
equilibrium concentration in the experiments performed with
heme-albumin we could show that the free heme is the active
neutrophil-stimulating component, which is inactivated by protein
association (Figure S2). With metHb, significant shedding was only
observed at heme concentrations above 1 mmolL1, which corresponds
to >16 mg/mL metHb. The shedding of CD62L correlated with the
nuclear condensation of granulocytes observed 2 hour after stimulation
(Figure 1D). It is important to note that these experiments were per-
formed in serum- and protein-free conditions, meaning that there were
no alternative heme-association sites available in the incubation medium.
F IGURE 1 Effect of heme solution characteristics on granulocyte activation. (A) Granulocytes were identified by flow-cytometry as the
CD14lowCD15high population. Surface expression of CD62L was analyzed in response to a 30-minute exposure to TNF-alpha or NaOH-dissolved
heme. Reduction of CD62L-signal indicates shedding. (B) Dose–effect relationship of NaOH-dissolved heme concentration and CD62L-shedding
(fraction of CD62L-negative granulocytes). Shown is the mean  SD of the logistic regression of data obtained from dose–response experiments
performed with blood from five healthy donors (10 heme concentrations were tested per experiment). (C) CD62L shedding induced by various heme
formulations: protein-free heme (NaOH-dissolved heme) in red, heme-albumin in blue, and metHb in brown. (D) DNA (DAPI) stains of nuclei of
neutrophil granulocytes exposed to heme at the concentrations indicated by the dots in Figure 1C. While at 16 lmolL1, heme-albumin induces
virtually no nuclear condensation, NaOH-dissolved heme exerts an apoptotic effect. The same can be observed at much higher concentrations
(250 lmolL1) when comparing heme-albumin to metHb. (E) Stopped-flow experiments of heme to hemopexin transfer. Heme transfer to hemopexin
can be considered a sensitive method for detecting free (ie, solubilized) heme. The fast fraction represents free heme, the intermediate fraction
represents heme only loosely bound to proteins or present in aggregates, and the slow fraction represents heme tightly bound to proteins. The
distribution of heme to these three compartments is visualized by the bar plots and is distinct for all three heme formulations
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To estimate concentrations of free heme or quasi-free heme
(eg loosely protein-associated) in the different experimental heme
solutions, we used stopped-flow spectrophotometry to measure
the fraction of heme that was available for rapid hemopexin bind-
ing (Figure 1E). In NaOH-dissolved heme, which induced CD62L
shedding at micromolar concentrations, approximately 80% of the
heme demonstrated an ultra-fast binding pattern (heme-hemo-
pexin complex formation completed within <100 milliseconds). In
contrast, the ultra-fast hemopexin-binding fraction of heme was
reduced to less than 10% in heme-albumin. In solutions of
metHb, the proportion of free heme available for ultra-rapid
hemopexin binding was found to be very low. These observations
suggest that in any physiological scenario in which heme might
be present in extracellular spaces as a component of a natural
hemoprotein, the concentration of free or quasi-free heme can be
expected to be very low, possibly below the minimum range
required to trigger granulocyte activation and other innate immu-
nity responses.
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F IGURE 2 Effect of heme solution
characteristics on macrophage and
endothelial cell viability, metabolic activity,
and HMOX1 expression. (A) Cellular ATP
as a fraction of control values in HUVECs
and mouse BMDMs after treatment with
protein-free heme (NaOH), heme-albumin,
metHb, or oxyHb for 8 hours. Identical
experiments were performed in cell culture
medium with or without serum (2% FCS
for HUVECs and 10% FCS for BMDMs).
Data represent the mean  SEM of six
biological replicates. (B) Extracellular flux
analysis of heme-exposed HUVECs.
Oxygen consumption rate (OCR) was
measured in HUVECs after exposure to a
range of concentrations of heme-albumin
(in the presence of 2% FCS) or NaOH-
dissolved heme in the absence of serum.
(C) Western blot analysis of HMOX1
protein in HUVECs after exposure to a
range of concentrations of heme-albumin
or NaOH-dissolved heme (block 1) or
heme-albumin, metHb, or oxyHb (block 2).
Proteins in the same block were run on
the same gel. (D) Western blot analysis of
HMOX1 protein in mouse BMDMs after
exposure to a range of concentrations of
heme-albumin
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3.2 | Effects of heme solution characteristics on
heme-triggered heme oxygenase induction, cell
viability, and metabolic disruption
Our initial experiments suggested that artificial preparations of protein-
free heme could trigger cellular responses that might not be reproduced
by physiological sources of heme in vivo. Before we aimed to character-
ize in more detail the putative inflammatory properties of the more
physiological protein-associated heme, we defined how protein-free
heme and protein-associated heme may affect cellular viability, metabo-
lism, and markers of heme exposure in endothelial cells (HUVECs) and
mouse bone marrow-derived macrophages (BMDMs). In serum-free
conditions, NaOH-dissolved heme (final pH 7.8) reduced cellular ATP in
both cell types in a dose-dependent manner after 8 hours of exposure
(Figure 2A). In contrast, less ATP depletion was observed during expo-
sure to heme-albumin, and no effect could be detected when either cell
type was exposed to metHb or oxyHb at concentrations of up to
500 lmolL1, even in the absence of serum. When the identical experi-
ments were performed in the presence of serum (2% FCS in endothelial
cells and 10% FCS in macrophage experiments), the heme-induced
effects were further reduced or completely eliminated.
We also confirmed the critical role of protein association in cellular
heme effects in a metabolic experiment using a Seahorse extracellular flux
analyzer (Figure 2B). This experiment demonstrated that under serum-free
conditions, 4 hours of exposure to NaOH-dissolved heme induced com-
plete deterioration of mitochondrial respiration at concentrations as low
as 10 lmolL1, while exposure to albumin-associated heme in the pres-
ence of 2% FCS stimulated respiratory capacity to levels above baseline.
The expression of heme oxygenase (HMOX1) can be considered a
direct signal of intracellular heme translocation in healthy cells. In
endothelial cells, we found that, in the absence of serum, heme-albumin
triggered a dose-dependent HMOX1 protein expression signal in an
exposure range of 0–175 lmolL1. In contrast, exposure to NaOH-dis-
solved heme resulted in virtually no signal, presumably as a result of the
strong toxicity of the treatment. Heme translocation with subsequent
HMOX1 induction was very limited upon treatment with metHb or
oxyHb (Figure 2C). This observation is consistent with the very low free
heme fraction in these solutions. Heme-albumin is also a robust inducer
of dose-dependent HMOX1 expression in BMDMs (Figure 2D).
3.3 | Protein-associated heme does not trigger
inflammation in human endothelial cells
Thus far, we have determined that protein association dramatically
reduces free heme availability and limits the range of heme-induci-
ble biological responses. As an experimental model, exposure to
heme-albumin in the presence of low concentrations of serum
may mimic the most severe conditions of heme exposure during
tissue trauma or hemolysis in vivo. We therefore explored
whether exposure of endothelial cells and macrophages to heme-
albumin or to the natural heme proteins, oxyHb and metHb, could
trigger inflammatory responses, which would justify the classifica-
tion of heme as a bona fide DAMP.
Principal component analysis (Figure 3A) of gene array expres-
sion data obtained from RNA extracted from nonstimulated
HUVECs and from HUVECs exposed to either 150 lmolL1
heme-albumin or IL-1b revealed a strongly dichotomous response
pattern triggered by the two treatments. The group of genes reg-
ulated by the archetypical proinflammatory stimulus IL-1b dis-
played virtually no overlap with the genes that were regulated by
heme-albumin. An enrichment analysis for gene functions revealed
that IL-1b-regulated genes (IL-1b up, red label) belonged to cate-
gories such as immune response, chemotaxis, cell adhesion, and
inflammation (Figure 3B). In contrast, no significant inflammation-
related enrichment was observed for the heme-albumin-triggered
response genes (heme-up, blue label), which were more characteris-
tic of categories such as response to unfolded proteins. More
specifically, as shown in Figure 3C, the top IL-1b-induced genes
were not induced by heme-albumin at 25, 75, or 150 lmolL1.
Heme-albumin, in contrast, induced HMOX1 in a dose-dependent
manner. The strictly dichotomous responses triggered by the
archetypical inflammatory stimulator IL-1b and by heme-albumin
were confirmed by RT-PCR analysis of the expression of SELE,
ICAM1, VCAM1, CCL20, HMOX1, and the oxidative response gene
ATF3 (Figure 3D). In the presence of 2% FCS, none of the initially
explored heme compounds (NaOH-dissolved heme, heme-albumin,
metHb, or oxyHb) induced appreciable secretion of IL-8 or upreg-
ulation of cell-surface VCAM1 over an exposure range of 10–
500 lmolL1 for 6 hours (Figure 3E).
F IGURE 3 Effect of hemoproteins on human endothelial cells. (A-C) Gene array analysis of gene expression (mRNA) changes in HUVECs
treated for 8 hours with IL-1b or heme-albumin (25 lmolL1, 75 lmolL1 and 150 lmolL1) (n = 4 experiments for each heme treatment,
n = 6 experiments for IL-1b). (A) Principal component analysis (PCA) of the standardized least-square means of all genes that were regulated
by more than 2-fold (FDR < 0.01). Each expressed gene is represented as a dot and color-coded for its expression category (up- or
downregulation by heme or IL-1b). The yellow enhancement indicates those genes that are further analyzed in (C). (B) Metacore enrichment
analysis for gene functions assigned to the IL-1b-upregulated genes (red bars) and heme-upregulated genes (blue bars) (regulation cut-off 4-
fold, FDR < 0.01). (C) Heatmap of the expression level of the 20 most IL-1b upregulated genes in comparison to the expression level in heme-
albumin treated HUVEC samples. The selected transcripts are color-coded (red: high expression; blue: low expression). (D) Relative mRNA
expression of proinflammatory molecules (inflammation) and oxidative stress (heme response) genes in HUVECs in response to IL-1b or
increasing concentrations of heme-albumin. Data represent the mean  SD of six replicates. (E) Concentration of IL-8 and VCAM1 in the cell
culture supernatant of HUVECs in response to increasing concentrations of NaOH-dissolved heme, heme-albumin, metHb, and oxyHb over an
exposure range of 10 to 500 lmolL1 for 6 hours. Experiments were performed in complete cell culture medium containing 2% FCS. Data
represent the mean  SD of six replicates
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3.4 | Protein-associated heme does not trigger
inflammation in mouse macrophages
In addition to endothelial cells, macrophages were considered
another possible target of heme-triggered proinflammatory activity.
As with endothelial cells, we started the analysis of macrophage
responses with a gene array study comparing changes in gene
expression induced by 50 and 200 lmolL1 heme-albumin and by
LPS. Figure 4A shows the cross-correlation analysis of all genes rep-
resented on the array. The results revealed a clear separation
between the LPS-treated samples and all other conditions, while the
heme-albumin-treated samples were not separated from the control
samples. Figure 4B shows a more detailed gene expression correla-
tion analysis of the samples treated with low (50 lmolL1, n = 4)
and high (200 lmolL1, n = 4) concentrations of heme-albumin. The
most significantly regulated genes at both concentrations were Spic,
a macrophage-restricted transcription factor with a role in red-pulp
macrophage differentiation; Hmox1, the iron exporter Scl40A1 (ferro-
portin); and the antioxidant response gene Gclm. This analysis there-
fore does not provide evidence of a heme-triggered inflammatory
response. In addition, a more detailed analysis reveals no significant
induction of LPS-induced genes by heme-albumin (Figure 4C). As
shown in Figure 4D, RT-PCR gene expression data for TNF-alpha,
IL-6, Spic, and Hmox1 from an independent set of experiments were
consistent with these results. We have also repeated these studies,
yielding identical results, with Hmox1-deficient macrophages. These
experiments exclude the possibility that exaggerated expression of
Hmox1 could explain the absence of inflammation (Figure 4E).
We also measured the secretion of the inflammatory mediators
TNF-alpha and IL-6 from mouse BMDMs into the culture medium
during treatment with NaOH-dissolved heme, heme-albumin, oxyHb,
and metHb for 18 hours (culture medium contained 10% FCS).
Again, compared to the archetypical proinflammatory stimulus LPS,
we did not detect appreciable cytokine secretion under most condi-
tions (Figure 5A). However, a weak TNF-alpha signal appeared in
macrophages that were treated with the highest concentration of
NaOH-dissolved heme (500 lmolL1). We therefore repeated this
experiment in serum-free medium and found the TNF-alpha secre-
tion response shifted to the left with a maximum signal at
50 lmolL1 heme (Figure 5B). At higher heme concentrations, TNF-
alpha secretion declined due to increasing toxicity, as indicated by a
decline in intracellular ATP (shown in red). Further experiments using
macrophages from different mouse knockout strains suggested that
this proinflammatory heme response in the serum-free model was a
result of signaling via the TLR4–MyD88–TRIF pathway (Figure 5C).
These experiments confirm a number of earlier reports and support
the idea that certain solutions derived from purified/crystalline heme
have the potential to induce weak TLR4-mediated inflammatory
responses in macrophages in the complete absence of plasma-
derived proteins.
In our last set of studies, we aimed to explore whether heme
could support a proinflammatory environment in vivo. In the first
model, subcutaneous Matrigel plugs were injected bilaterally into
the flanks of wild-type C57Bl/6 mice. The plugs were recovered for
analysis after 5 days. The plugs were enriched with either LPS
(1 lg/mL), heme-albumin (1 mmolL1), or metHb (1 mmolL1).
After 5 days in situ, the LPS-enriched plugs showed a cellular infil-
trate rich in Ly6+ neutrophils and iNOS-expressing F4/80+ macro-
phages. In contrast, the heme-albumin and metHb-enriched plugs
were not different from control plugs, exhibiting few infiltrating
macrophages (Figure 6A). We also measured TNF-alpha mRNA
expression of the cellular infiltrate in the different plugs by RT-PCR
(Figure 6B). While control and heme-enriched plugs had minimal
TNF-alpha expression, significantly higher levels of TNF-alpha mRNA
were found in the LPS-enriched plugs.
In the second model, we injected phenylhydrazine (PHZ) into
mice to induce severe and acute hemolysis, with a drop in hemat-
ocrit from 48% to 31% within 48 hours (Figure 6D). This treatment
was accompanied by drastic increases in heme concentrations in F4/
80+ liver macrophages (Figure 6C). However, compared to treatment
with LPS, systemic hemolysis did not provoke enhanced expression
of TNF-alpha mRNA or IL-6 mRNA in F4/80+ Kupffer cells of the
liver (Figure 6E).
4 | DISCUSSION
The overall framework of Hb-mediated disease is based on three
predominant hypotheses, which link specific biochemical properties
of Hb and heme with pathophysiological processes that can occa-
sionally be observed in patients with hemolysis or at sites of local
Hb accumulation.2 The first process links the nitric oxide (NO)
F IGURE 4 Effect of hemoproteins on bone marrow-derived mouse macrophages. (A-C) Gene array analysis of gene expression (mRNA)
changes in mouse BMDMs treated for 8 hours with LPS (10 ng/mL) or heme-albumin (50 lmolL1 and 200 lmolL1) (n = 4 experiments per
condition). (A) Cross-correlation plot of gene expression data of all genes across all treatment conditions. The data show a clear separation of
LPS-treated samples from all other conditions. (B) Dot-plot and correlation analysis of the gene expression data from BMDMs treated with
50 lmolL1 or 200 lmolL1 heme-albumin (for 8 hours) relative to control cells. Genes that are significantly up- or downregulated by
50 lmolL1 heme are highlighted in red. Representative heme-response genes are labeled. (C) Heatmap of mRNA expression data across
exposure conditions for the most LPS-upregulated genes (red: high expression; blue: low expression). (D) RT-PCR analysis of mRNA expression
in wild-type mouse BMDMs (tamoxifen-treated Hmox1 fl/fl Cre/) after exposure to the indicated stimuli for 8 hours. Data are presented
relative to control mRNA levels and represent 6–8 independent experiments. (E) Identical analysis as in (D) with Hmox1-knockout macrophages
(tamoxifen-treated Hmox1 fl/fl Cre+/). Western blot demonstrates HMOX1 protein in wild-type (Cre/) and knockout (Cre+/) macrophages
after heme treatment
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F IGURE 5 Heme-triggered inflammation under protein-free conditions. (A) Concentrations of TNF-alpha (pg/mL) and IL-6 (pg/mL) in the
cell culture supernatant of mouse BMDM after treatment with a concentration gradient of heme-albumin, NaOH-dissolved heme, metHb,
oxyHb, or LPS (10 ng/mL) for 18 hours. Experiments were performed in complete culture medium containing 10% FCS. (B) Concentration of
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18 hours. In parallel, cellular ATP was determined as a measure of viability and is expressed as a percentage of untreated cells. (C) TNF-alpha
mRNA expression in mouse BMDMs that were treated with NaOH-dissolved heme (50 lmolL1) or LPS (10 ng/mL) for 4 hours in serum-free
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reactivity of oxyHb to a cascade of cell-free Hb extravasation,
hemolysis-associated NO-depletion, and vasoconstriction.21–23 The
second biochemical process relates to the ability of Hb to facilitate
oxidative reactions outside of the reducing environment of the RBC,
leading to the accumulation of ferric metHb(Fe3+) in tissue.24 In sub-
sequent reactions, metHb or metHb-derived heme participates in
redox chain reactions that lead to the accumulation of modified
lipids and proteins, as well as to heme degradation and to the
release of free iron.19,25 Ultimately, these processes can result in
oxidative tissue injury, which may be accompanied by a tissue regen-
erative response or by secondary inflammation.26 The third process
suggests that free heme could be recognized by innate immunity
receptors as an endogenous DAMP, which may directly activate
inflammatory signaling pathways in leukocytes and endothelial cells.
This mechanism has been suggested to contribute to the chronic
inflammatory state that is observed in sickle cell disease.10 Further-
more, various studies in sickle cell disease mouse models have
demonstrated that the injection of heme solutions can trigger
endothelial hyperactivation, leading to vasoocclusion or an acute
chest syndrome-like phenotype.11,27 Purified heme was found to be
an activator of TLR4 8,11,27 in some studies and of the inflammasome
9 in others, and these activities were considered to be the molecular
mechanism behind the coexistence of inflammation and hemolysis.
Our current study focused on the third pathophysiological pro-
cess and aimed to systematically address in different cell culture and
animal models the putative proinflammatory activity of hemopro-
teins. The hypothesis that cell-free Hb or Hb-derived heme may
function as a DAMP that signals tissue injury to the innate immune
system, initiating an enhanced immune response, is appealing. How-
ever, clinical experience indicates that a sterile tissue injury with a
hematoma, where significant free Hb and heme accumulation occurs,
is usually not accompanied by an uncontrolled inflammatory
response. We have considered the possibility that pathophysiological
responses to heme could be related to its physicochemical properties
and macromolecular interactions. Therefore, variation in heme prepa-
rations may explain the differing observations regarding its effects
on the inflammatory system.
Using protein-associated heme as a stimulus and in the presence
of low concentrations of serum, we were not able to detect inflam-
matory responses in macrophages or endothelial cells, even during
exposure to very high concentrations of heme (500 lmolL1). This
was true not only for stimulation with the natural hemoproteins fer-
rous and ferric Hb, but also for albumin-associated heme. The heme-
albumin solution that we used as a model for protein-associated
heme was a mixture of albumin and heme in a 1:4 molar ratio. This
solution contained a significant fraction of heme that was only
weakly associated with the protein. We do not know of any patho-
logical condition that would lead to such a dramatic accumulation of
loosely protein-associated heme remaining available for interactions
with inflammatory cells after Hb degradation. However, similar to
Hb, heme-albumin did not induce an inflammatory response in
macrophages or endothelial cells in the presence of low concentra-
tions of serum. To escalate the level of cellular heme exposure, we
tested Hmox1-deficient macrophages and found the same lack of an
inflammatory response. The only consistent response that we
observed to heme exposure included the activation of an oxidative
stress response in endothelial cells at higher heme concentrations
and the induction of a set of genes in mouse BMDMs that are char-
acteristic of Hb-iron-handling macrophages in the spleen including
the transcriptional repressor Spic, Hmox1, and ferroportin (Slc40A1).
Only under protein-free conditions did we observe a limited
heme-induced TNF-alpha response in cultured macrophages, which
was triggered via signaling of the classical TLR4–MyD88–TRIF path-
way of NF-kB activation.28 However, even this response was small
compared to the LPS response observed in the same cells, and it
occurred only at the boundary of heme-induced cytotoxicity. To fur-
ther support the hypothesis that the extent and nature of macro-
molecular associations determine whether heme does or does not
function as an activator of immune cells, we explored heme- and
hemoprotein-triggered activation of neutrophil granulocytes in
washed peripheral whole blood cells. In the absence of serum, this
model appears to be extremely sensitive for the study of the dose-
response relationships of heme-triggered leukocyte activation.6,29,30
Our experiments demonstrated that as free heme concentrations
decline with the increasing availability and strength of heme–protein
associations (protein-free heme  heme-albumin < metHb), neu-
trophil CD62L shedding disappears. Our studies were not designed
to structurally characterize the neutrophil-activating species in pro-
tein-free heme solutions. However, in the absence of macromolecu-
lar associations, such as in an aqueous solution of purified iron
protoporphyrin IX, aggregates of heme are known to form. We also
found by dynamic light scattering that protein-free aqueous heme
solutions at neutral pH values contained aggregates with a particle
size of up to 1000 nm (mean diameter, 320 nm; data not shown).
Such aggregates, which were not detectable in protein-associated
heme solutions, are a strong candidate for an innate immunity recep-
tor activator. Alternatively, the complete absence of other proteins
may provide an environment for low-affinity interactions of mono-
F IGURE 6 Effects of heme on inflammatory pathways in vivo. (A) Subcutaneous Matrigel plugs were explanted 5 days after implantation
and stained for Ly6 (granulocytes), F4/80 (macrophages), and iNOS. Plugs were enriched with LPS (1 lg/mL), metHb (1 mmolL1), or heme-
albumin (1 mmolL1). (B) The cellular infiltrate from control, heme-albumin and LPS enriched plugs were isolated at day 5 after injection by
laser-microdissection (LCM), and TNF-alpha mRNA expression was analyzed by RT-PCR. Relative expression levels were normalized for HPRT
mRNA expression and are displayed as 2dCT (TNF  HPRT). (C) FACS analysis of F4/80 expression on liver cells before and after purification
with F4/80-conjugated magnetic beads. (D) Hematocrit levels of mice treated with saline (control) or phenylhydrazine (PHZ 90 mg/kg),
determined 48 hours after treatment. (E) Analysis of heme content, TNF-alpha mRNA expression, and IL-6 mRNA expression in F4/80+
macrophages of the liver from control mice and mice treated with PHZ or LPS (0.5 mg/kg) for 4 hours
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or oligomeric heme with TLR4 or with components of the inflamma-
some in vitro.
The absence of a liver macrophage inflammatory response during
severe intravascular hemolysis and the absence of inflammatory acti-
vation of invading macrophages in heme-enriched Matrigel plugs
substantiated our principal findings in two in vivo models.
Our in vitro and in vivo studies suggest that physiological heme
is likely not a bona fide activator of inflammation. However, it
might still be possible that heme or Hb could alter inflammation in
more complex models of sequential priming and activation pro-
cesses or as a synergistic agonists with inflammatory activators.31,32
Heme could, for example, enhance priming of leukocytes for subse-
quent activation by classical inflammatory stimuli. As an example of
a synergistic model it has been observed that Hb could enhance
macrophage activation by multiple TLR agonists by a so far unde-
fined mechanism.33
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